Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.69
-0.14 (-1.79%)
Feb 21, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $150.20 million as of February 21, 2025.
Market Cap
150.20M
Enterprise Value
136.67M
1-Year Change
n/a
Ranking
Category
Stock Price
7.69
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $150.20M, a decrease of -1.27%. That is a compound annual growth rate of -2.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 150.20M | -3.39% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |